FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Salvatore Butera

Research Profile

Living Beings

Disorders

Physiology

Chemicals & Drugs

Anatomy

Phenomena

Virus Activation

Co-author Network

Publications

TOP 3
James M Smith; Allison Dauner; Bin Li; Priya Srinivasan; James Mitchell; Michael Hendry; Dennis Ellenberger; Salvatore T Butera; Ron A Otten
Generation of a dual RT Env SHIV that is infectious in rhesus macaques.
Nattawan Promadej-Lanier; Debra L Hanson; Priya Srinivasan; Wei Luo; Debra R Adams; Patricia C Guenthner; Salvatore T Butera; Ron A Otten; Ellen N Kersh
Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges.
Ellen N Kersh; Wei Luo; Debra R Adams; Priya Srinivasan; James M Smith; Nattawan Promadej-Lanier; Dennis Ellenberger; J Gerardo Garcia-Lerma; Salvatore T Butera; Ron A Otten
Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Salvatore Butera (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: James M Smith; Allison Dauner; Bin Li; Priya Srinivasan; James Mitchell; Michael Hendry; Dennis Ellenberger; Salvatore T Butera; Ron A Otten
Generation of a dual RT Env SHIV that is infectious in rhesus macaques.
Journal of medical primatology 2010;39(4):213-23.
2010: Nattawan Promadej-Lanier; Debra L Hanson; Priya Srinivasan; Wei Luo; Debra R Adams; Patricia C Guenthner; Salvatore T Butera; Ron A Otten; Ellen N Kersh
Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges.
Journal of acquired immune deficiency syndromes (1999) 2010;53(5):574-81.
2009: Ellen N Kersh; Wei Luo; Debra R Adams; Priya Srinivasan; James M Smith; Nattawan Promadej-Lanier; Dennis Ellenberger; J Gerardo Garcia-Lerma; Salvatore T Butera; Ron A Otten
Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model.
AIDS research and human retroviruses 2009;25(9):905-17.
2009: Nattawan Promadej-Lanier; James M Smith; Priya Srinivasan; Clare F McCoy; Salvatore T Butera; A David Woolfson; R Karl Malcolm; Ron A Otten
Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.
Journal of medical primatology 2009;38(4):263-71.
2009: Smita S Kulkarni; Alan Lapedes; Haili Tang; S Gnanakaran; Marcus G Daniels; Ming Zhang; Tanmoy Bhattacharya; Ming Li; Victoria R Polonis; Francine E McCutchan; Lynn Morris; Dennis Ellenberger; Salvatore T Butera; Robert Bollinger; Bette T Korber; Ramesh S Paranjape; David C Montefiori
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.
Virology 2009;385(2):505-20.
2008: Nattawan Promadej-Lanier; Priya Srinivasan; Kelly Curtis; Debra R Adams; Caryn Kim; Wei Luo; Hongwei Jia; Shambavi Subbarao; Ron A Otten; Salvatore T Butera
Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques.
Virology 2008;375(2):492-503.
2008: Ellen N Kersh; Wei Luo; Debra R Adams; James Mitchell; J Gerardo Garcia-Lerma; Walid Heneine; Thomas M Folks; Salvatore T Butera; Ron A Otten
Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques.
AIDS research and human retroviruses 2008;24(4):543-6.
2007: Michael Aidoo; Ron A Otten; Vanessa Rodriguez; Carlos A Sariol; Melween Martinez; Edmundo Kraiselburd; Harriet Robinson; Thomas M Folks; Salvatore T Butera; Dennis Ellenberger
Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations.
Vaccine 2007;25(35):6474-81.
2007: Shambavi Subbarao; Artur Ramos; Caryn Kim; Debra Adams; Michael Monsour; Salvatore T Butera; Thomas M Folks; Ron A Otten
Direct stringency comparison of two macaque models (single-high vs. repeat-low) for mucosal HIV transmission using an identical anti-HIV chemoprophylaxis intervention.
Journal of medical primatology 2007;36(4-5):238-43.
2007: Athena P Kourtis; Chris C Ibegbu; Regan Theiler; Yong-Xian Xu; Pooja Bansil; Denise J Jamieson; Michael Lindsay; Salvatore T Butera; Ann Duerr
Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
The Journal of infectious diseases 2007;195(7):965-72.
2007: Zahra Toossi; Harriet Mayanja-Kizza; Stephen D Lawn; Christina S Hirsch; L Davis Lupo; Salvatore T Butera
Dynamic variation in the cellular origin of HIV type 1 during treatment of tuberculosis in dually infected subjects.
AIDS research and human retroviruses 2007;23(1):93-100.
2006: Shambavi Subbarao; Ron A Otten; Artur Ramos; Caryn Kim; Eddie Jackson; Michael Monsour; Debra R Adams; Sheila Bashirian; Jeffrey Johnson; Vincent Soriano; Ana Rendon; Michael G Hudgens; Salvatore T Butera; Robert Janssen; Lynn A Paxton; Alan E Greenberg; Thomas M Folks
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.
The Journal of infectious diseases 2006;194(7):904-11.
2006: Dennis Ellenberger; Ron A Otten; Bin Li; Michael Aidoo; I Vanessa Rodriguez; Carlos A Sariol; Melween Martinez; Michael Monsour; Linda S Wyatt; Michael G Hudgens; Edmundo Kraiselburd; Bernard Moss; Harriet Robinson; Thomas M Folks; Salvatore T Butera
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
Virology 2006;352(1):216-25.
2006: Caryn N Kim; Debra R Adams; Sheila Bashirian; Salvatore T Butera; Thomas M Folks; Ron A Otten
Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Journal of medical primatology 2006;35(4-5):210-6.
2005: Dennis Ellenberger; Linda S Wyatt; Bin Li; Suzan Buge; Nattawan Lanier; I Vanesssa Rodriguez; Carlos A Sariol; Melween Martinez; Michael Monsour; Jennifer Vogt; James Smith; Ron A Otten; David Montefiori; Edmundo Kraiselburd; Bernard Moss; Harriet Robinson; Janet M McNicholl; Salvatore T Butera
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immature VLPs.
Virology 2005;340(1):21-32.
2005: James M Smith; Rama Rao Amara; Linda S Wyatt; Dennis Ellenberger; Bin Li; James G. Herndon; Milloni Patel; Sunita Sharma; Lakshmi Chennareddi; Salvatore T Butera; Janet M McNicholl; Harold M McClure; Bernard Moss; Harriet L Robinson
Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses.
AIDS research and human retroviruses 2005;21(2):140-4.
2005: Ron A Otten; Debra R Adams; Caryn N Kim; Eddie Jackson; Jennifer K Pullium; Kemba Lee; Lisa A Grohskopf; Michael Monsour; Salvatore T Butera; Thomas M Folks
Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
The Journal of infectious diseases 2005;191(2):164-73.
2005: James F Jones; Prasad S Kulkarni; Salvatore T Butera; William C Reeves
GB virus-C--a virus without a disease: we cannot give it chronic fatigue syndrome.
BMC infectious diseases 2005;5():78.
2004: James M Smith; Rama Rao Amara; David Campbell; Yan Xu; Milloni Patel; Sunita Sharma; Salvatore T Butera; Dennis Ellenberger; Hong Yi; Lakshmi Chennareddi; James G. Herndon; Linda S Wyatt; David Montefiori; Bernard Moss; Harold M McClure; Harriet L Robinson
DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.
AIDS research and human retroviruses 2004;20(12):1335-47.
2004: James M Smith; Rama Rao Amara; Harold M McClure; Milloni Patel; Sunita Sharma; Hong Yi; Lakshmi Chennareddi; James G. Herndon; Salvatore T Butera; Walid Heneine; Dennis Ellenberger; Bharat Parekh; Patricia L Earl; Linda S Wyatt; Bernard Moss; Harriet L Robinson
Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques.
AIDS research and human retroviruses 2004;20(6):654-65.
2004: Ron A Otten; Debra R Adams; Caryn N Kim; Jennifer K Pullium; Tamela Sawyer; Eddie Jackson; Thomas M Folks; Salvatore T Butera
Chronic HIV-2 infection protects against total CD4+ cell depletion and rapid disease progression induced by SHIV89.6p challenge.
AIDS (London, England) 2004;18(8):1127-35.
2004: Dennis Ellenberger; Bin Li; James Smith; Hong Yi; Thomas M Folks; Harriet Robinson; Salvatore T Butera
Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms.
Virology 2004;319(1):118-30.
2003: Athena P Kourtis; Salvatore T Butera; Chris C Ibegbu; Laurent Belec; Ann Duerr
Breast milk and HIV-1: vector of transmission or vehicle of protection?
The Lancet infectious diseases 2003;3(12):786-93.
2003: Chunfu Yang; Ming Li; Khanchit Limpakarnjanarat; Nancy L Young; Thomas W Hodge; Salvatore T Butera; Janet M McNicholl; Timothy Mastro; Renu B Lal
Polymorphisms in the CCR5 coding and noncoding regions among HIV type 1-exposed, persistently seronegative female sex-workers from Thailand.
AIDS research and human retroviruses 2003;19(8):661-5.
2003: Prasad S Kulkarni; Salvatore T Butera; Ann Duerr
Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
AIDS reviews 2003;5(2):87-103.
2002: Dennis Ellenberger; Bin Li; L Davis Lupo; Sherry Owen; John N Nkengasong; Madeleine Sassan Kadio-Morokro; James Smith; Harriet Robinson; Marta Ackers; Alan Greenberg; Thomas M Folks; Salvatore T Butera
Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development.
Virology 2002;302(1):155-63.
2002: Tracy L Pisell; Irving F Hoffman; Charles S Jere; Sarah B Ballard; Malcolm E Molyneux; Salvatore T Butera; Stephen D Lawn
Immune activation and induction of HIV-1 replication within CD14 macrophages during acute Plasmodium falciparum malaria coinfection.
AIDS (London, England) 2002;16(11):1503-9.
2002: Stephen D Lawn; Salvatore T Butera; Thomas M Shinnick
Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis.
Microbes and infection / Institut Pasteur 2002;4(6):635-46.
2002: Utaiwan Utaipat; Ann Duerr; Donna L Rudolph; Chunfu Yang; Salvatore T Butera; Davis Lupo; Tracy L Pisell; Arunrat Tangmunkongvorakul; Nuonchuen Kamtorn; Niwes Nantachit; Tippavan Nagachinta; Vinai Suriyanon; Valerie Robison; Kenrad E Nelson; Nopporn Sittisombut; Renu B Lal
Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
AIDS research and human retroviruses 2002;18(1):1-11.
2001: Stephen D Lawn; Tracy L Pisell; Christina S Hirsch; M Wu; Salvatore T Butera; Zahra Toossi
Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection.
The Journal of infectious diseases 2001;184(9):1127-33.
2001: S D Lawn; Salvatore T Butera; Thomas M Folks
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.
Clinical microbiology reviews 2001;14(4):753-77, table of contents.
2001: Salvatore T Butera; Tracy L Pisell; Khanchit Limpakarnjanarat; Nancy L Young; Thomas W Hodge; Timothy Mastro; Thomas M Folks
Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1.
AIDS research and human retroviruses 2001;17(8):735-44.
2001: Jennifer K Pullium; Debra R Adams; Eddie Jackson; Caryn N Kim; Dawn Smith; Robert Janssen; K Gould; Thomas M Folks; Salvatore T Butera; Ron A Otten
Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission.
The Journal of infectious diseases 2001;183(7):1023-30.
2001: Tracy L Pisell; O Ho; G Lee; Salvatore T Butera
Spectrum of cdk-9 inhibitor activity against HIV-1 replication among various models of chronic and latent infection.
Antiviral chemistry & chemotherapy 2001;12 Suppl 1():33-41.
2000: Salvatore T Butera
Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities.
Antiviral research 2000;48(3):143-76.
2000: BD Roberts; Chou-Pong Pau; Hillard Weinstock; Walid Heneine; Salvatore T Butera
Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro.
AIDS (London, England) 2000;14(17):2797-8.
2000: Salvatore T Butera; J Brown; M E Callahan; Sherry Owen; AL Matthews; D D Weigner; Louisa E Chapman; Paul A Sandstrom
Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses.
Journal of the American Veterinary Medical Association 2000;217(10):1475-9.
2000: S D Lawn; Salvatore T Butera
Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection.
Journal of virology 2000;74(21):10256-9.
2000: Ron A Otten; Dawn Smith; Debra R Adams; Jennifer K Pullium; Eddie Jackson; Caryn N Kim; H Jaffe; Robert Janssen; Salvatore T Butera; Thomas M Folks
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).
Journal of virology 2000;74(20):9771-5.
2000: Stephen D Lawn; Shambavi Subbarao; Thomas C Wright; Tammy Evans-Strickfaden; Tedd V Ellerbrock; Jeffrey Lennox; Salvatore T Butera; Clyde E Hart
Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.
The Journal of infectious diseases 2000;181(6):1950-6.
2000: S D Lawn; BD Roberts; George E Griffin; Thomas M Folks; Salvatore T Butera
Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.
Journal of virology 2000;74(1):139-45.
1999: Stephen D Lawn; R J Shattock; JW Acheampong; Renu B Lal; Thomas M Folks; George E Griffin; Salvatore T Butera
Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans.
AIDS (London, England) 1999;13(16):2231-7.
1999: J W Critchfield; O Ho; BD Roberts; C Van Lint; E Verdin; Salvatore T Butera
Isoquinolinesulphonamide derivatives inhibit transcriptional elongation of human immunodeficiency virus type 1 RNA in a promyelocytic model of latency.
Antiviral chemistry & chemotherapy 1999;10(5):275-84.
1999: BD Roberts; Salvatore T Butera
Host protein incorporation is conserved among diverse HIV-1 subtypes.
AIDS (London, England) 1999;13(3):425-7.
1997: BD Roberts; Salvatore T Butera
Changes in CXC-chemokine receptor-4 expression during HIV-1 replication are independent of CD4 modulations.
AIDS (London, England) 1997;11(15):1886-8.
1997: J W Critchfield; J E Coligan; Thomas M Folks; Salvatore T Butera
Casein kinase II is a selective target of HIV-1 transcriptional inhibitors.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6110-5.
1997: T C Woods; BD Roberts; Salvatore T Butera; Thomas M Folks
Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells.
Blood 1997;89(5):1635-41.
1997: BD Roberts; G Fang; Salvatore T Butera
Influence of cell cycle on HIV-1 expression differs among various models of chronic infection.
Archives of virology 1997;142(6):1087-99.
1996: Salvatore T Butera; BD Roberts; Thomas M Folks
Ligand passing by the p75 tumour necrosis factor receptor enhances HIV-1 activation.
Cytokine 1996;8(10):745-50.
1996: J W Critchfield; Salvatore T Butera; Thomas M Folks
Inhibition of HIV activation in latently infected cells by flavonoid compounds.
AIDS research and human retroviruses 1996;12(1):39-46.
1995: Salvatore T Butera; BD Roberts; J W Critchfield; G Fang; T McQuade; S J Gracheck; Thomas M Folks
Compounds that target novel cellular components involved in HIV-1 transcription.
Molecular medicine (Cambridge, Mass.) 1995;1(7):758-67.
1994: Salvatore T Butera; BD Roberts; L Lam; Thomas W Hodge; Thomas M Folks
Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency.
Journal of virology 1994;68(4):2726-30.
1993: Salvatore T Butera
Cytokine involvement in viral permissiveness and the progression of HIV disease.
Journal of cellular biochemistry 1993;53(4):336-42.
1993: Salvatore T Butera; BD Roberts; K Leung; Gary Nabel; Thomas M Folks
Tumor necrosis factor receptor expression and signal transduction in HIV-1-infected cells.
AIDS (London, England) 1993;7(7):911-8.
1993: Salvatore T Butera; BD Roberts; Thomas M Folks
Regulation of HIV-1 expression by cytokine networks in a CD4+ model of chronic infection.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(2):625-34.
1992: Salvatore T Butera; Thomas M Folks
Application of latent HIV-1 infected cellular models to therapeutic intervention.
AIDS research and human retroviruses 1992;8(6):991-5.
1991: V L Perez; Thomas Rowe; J S Justement; Salvatore T Butera; C H June; Thomas M Folks
An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(9):3145-8.
1991: Salvatore T Butera; V L Perez; B Y Wu; Gary Nabel; Thomas M Folks
Oscillation of the human immunodeficiency virus surface receptor is regulated by the state of viral activation in a CD4+ cell model of chronic infection.
Journal of virology 1991;65(9):4645-53.
1991: N J Besansky; Salvatore T Butera; S Sinha; Thomas M Folks
Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression.
Journal of virology 1991;65(5):2695-8.
1991: Salvatore T Butera; V L Perez; N J Besansky; W C Chan; B Y Wu; Gary Nabel; Thomas M Folks
Extrachromosomal human immunodeficiency virus type-1 DNA can initiate a spreading infection of HL-60 cells.
Journal of cellular biochemistry 1991;45(4):366-73.